<DOC>
	<DOCNO>NCT00191802</DOCNO>
	<brief_summary>The purpose study evaluate acceptance subcutaneous drug teriparatide 6 month therapy patient severe osteoporosis Canada , evaluate often patient actually able use injection ; obtain additional safety data ( side effect data ) supplement exist database adverse event report to-date clinical trial patient treat teriparatide ; document prior use osteoporosis therapy patient population , ongoing use osteoporosis therapy study ; describe baseline demographic disease state severely osteoporotic patients.The purpose study extension continue assess acceptance subcutaneous drug teriparatide 18 month therapy patient severe osteoporosis Canada , continue assess often patient actually able use injection ; obtain additional safety data ( side effect ) supplement exist database adverse event report date clinical trial patient treat teriparatide .</brief_summary>
	<brief_title>Compliance Acceptance Teriparatide Injection Severely Osteoporotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Postmenopausal woman OR man least 30 year age ( long bone growth ) In opinion investigator : The patient must severe osteoporosis ( define low bone mass AND fracture relate osteoporosis ) , high risk fracture despite currently available therapy Patients fail show intolerant currently commercially available osteoporosis therapy . ( Failure therapy : fracture , significant loss bone mass ) There medical cause osteoporosis ( call idiopathic osteoporosis ) except low estrogen ( woman ) low testosterone ( men ) In opinion investigator , patient learn use pen type injection delivery system able use either alone appropriate assistance Must able understand sign approve informed consent document Must able come followup visit duration study . High blood calcium level , high parathyroid hormone level blood , high level blood test call alkaline phosphatase n't explain yet . Known suspect bone disease osteoporosis Any medical condition might increase patient 's baseline risk bone tumor ( include prior radiation skeleton , Paget 's disease , previous bone tumor ) . Recent currently active kidney stone , OR major problem kidney function Serious ongoing medical problem incompatible study ( assessed investigator )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>